June 2014

Patient radiation dose drops 61% with imaging changes ()
Fan dies after heart attack at World Cup ()
Choosing Wisely: Beyond the Low Hanging Fruit ()
Finding a Balance: Bettering Costs & Care with Bulk Buys ()
Valve Volumes: Growing Demand, But There’s a Catch ()
Getting to the Heart of Heart Failure Management ()
Opportunity Knocks: Starting a Peripheral Artery Disease Program ()
Local Decisions, National Implications & You ()
Lines & Latitude ()
Doctors without (state) borders ()
Cholesterol Conundrum: Making Guidelines Work for You ()
Early post-op visits to PCP reduce 30-day readmissions ()
Poor hospital IT security puts pacemakers at risk ()
Integration deal weds Michigan Heart, IHA ()
Regadenoson safe for perfusion CMR with few adverse events ()
Outpatient EHR-based tool facilitates follow-up, safety ()
Costs averted with cardiac surgery CME could be substantial ()
Mount Sinai Heart establishes pioneering center for medical devices to advance cardiovascular medicine ()
3+ hour TV watching may increase cardiac mortality risk ()
Recall targets guidewires used in vascular procedures ()
Study published in Atherosclerosis provides first large-scale, real-world evidence of link between low LDL particle levels and reduced risk of cardiovascular disease ()
Boehringer Ingelheim’s investigational antidote for Pradaxa (dabigatran etexilate mesylate) receives FDA breakthrough therapy designation ()
Dr. Jacobs of Johns Hopkins All Children’s Heart Institute leads cardiac healthcare mission in Jamaica ()
Meltzer, Yancy receive American Heart Association’s top volunteer award ()
Northwestern Medicine cardiologist is American Heart Association Physician of the Year ()
FDA clears olmesartan after safety review ()
Left radial PCI reduces operators’ radiation exposure by half ()
Less radiation, more monitoring ()
Insertable cardiac monitor increases detection of afib post-stroke ()
30-day ECG monitoring spots candidates for anticoagulation ()
Recipe for heart health? Canola oil reduces risk in diabetics ()
Next-gen scans cut radiation dose by 61% in CT angiography patients ()
Male, elderly & 100+ cigarette history? That’s enough for USPSTF ()
Diabetes & heart failure: A delicate balancing act ()
Cardiologist’s early suspicions prove right ()
Telehealth helps cardiology program grow its market ()
Bill adds socioeconomic factors to readmissions formula ()
CRT benefits women with left bundle branch block more than men ()
Angiography as good as FFR & IVUS for post-PCI long-term survival ()
FDA requires thromboembolism warning on testosterone products ()
Congenital heart disease longevity increasing in Quebec ()
Antidepressants not likely to increase risk of cardiac birth defects ()
Thorough market assessment quickly pays off for physician network ()
Costs rise despite drop in ED length of stay for heart failure ()
CXO: Making patient experience a C-suite priority ()
Worthy—and succinct—advice ()
With $1B and a top rating, service line still strives for better ()
So you want a successful service line? Follow these 12 steps ()
FDA approves next-gen Sapien valve ()
Thrombolysis for pulmonary embolism may lower mortality but raise bleeding risks ()
Measures & money ()
No substantial benefit found in lowering blood pressure past 120 mmHg ()
2D echo may lead to inaccurate sizing in half of TAVR patients ()
It’s not personal: Genotyping may add no value for warfarin dosing ()
Early visits may provide key to lowering atrial fibrillation readmissions ()
Partnership uses data linkage to improve cardiac, diabetes care ()
Statement helps tailor care for women with suspected ischemic heart disease ()
Preoperative beta-blocker use may not help with CABG ()
Bayer may be next in line for anticoagulant lawsuits ()
Inpatient quality analysis zooms in on acute MI ()
Length of stay, prior hospitalization foreshadow 30-day stroke readmissions ()
Medtronic ponies up $43B to buy Covidien ()
A break for CABG? Readmissions measure uses clinical data ()
CPAP bests supplemental oxygen for lowering blood pressure ()
FDA panel votes in favor of drug-coated balloon for PAD ()
EKOS initiates a pivotal new study in patients with chronic deep vein thrombosis and post-thrombotic syndrome ()
Global leader projects introduction of IN.PACT Admiral Drug-coated Balloon to U.S. market in early FY16 ()
First patient receives HeartAssist5 VAD following CE mark approval ()
FDA OKs CoreValve for high-risk patients ()
When the price is not right ()
Cardiologist cries foul over $135K tab at strip club ()
Despite more complications, women on par with men after PAD interventions ()
Six-minute MRI may rival CT for evaluating ischemic stroke ()
This is going to hurt: $343 lipid tests and $2,924 MRIs ()
Livid over lipids? Brits bicker about proposed cholesterol guidelines ()
CCTA-guided CAD therapies help reduce LDL levels ()
Transitional care for heart failure doesn’t dent 30-day readmissions ()
Increasing radial PCI use even slightly may lower bleeding rates ()
Symposium highlights service line strategies, innovations ()
Pradaxa gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism ()
Toshiba’s cardiovascular x-ray provides flexibility and makes exams safer during pediatric interventions ()
EHR-based intervention for secondary stroke prevention flops ()
Rivaroxaban appears safe, effective for elderly patients ()
CABG with diabetes carries heavy cost burden in China ()
Cook Medical makes Zilver PTX drug-eluting stent available in Canada ()
EXCITE clinical trial data reported at NCVH demonstrates acute, superior procedural success ()
LUMEDX and Scientific Software Solutions announce strategic partnership ()
Medtronic launches Advisa and Ensura SR MRI SureScan pacemaker Systems in Europe ()
Drop in volume puts drag on interventional device market ()
69% of hospitals exceed average mortality risk for carotid artery stenting ()
Turning 90 ()
ICD use improves survival in less severe heart failure patients ()
Off-pump CABG shows short- but not long-term kidney benefits ()
67% of diabetic angina patients see quality of life gains with ranolazine ()
Obesity offers no survival edge and poses earlier stroke risk ()
SMARTCare holds potential to save billions in heart care costs ()
Tool IDs patients with poor outcomes after TAVR ()
Portal lets physicians review industry disclosures ()
Using LDL particle number to guide statin therapy in high-risk patients ()